Survival benefit from bevacizumab in newly diagnosed glioblastoma (GBM) according to transcriptional subclasses.
Jason T. Huse
No relevant relationships to disclose
Kathryn Beal
No relevant relationships to disclose
Jianan Zhang
No relevant relationships to disclose
Edward R. Kastenhuber
No relevant relationships to disclose
Thomas Joseph Kaley
No relevant relationships to disclose
Lauren E. Abrey
Employment or Leadership Position - Roche
Philip H. Gutin
Consultant or Advisory Role - Novocure; Pharmaco-Kinesis
Cameron W Brennan
No relevant relationships to disclose
Antonio Marcilio Padula Omuro
Consultant or Advisory Role - Novocure; Roche